Buchumschlag

Genetic deficiency or pharmacological inhibition of cGAS–STING signalling suppresses kidney inflammation and fibrosis

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Baihai Jiao, Changlong An, Hao Du, Melanie Tran, Duomeng Yang, Yuqi Zhao, Penghua Wang, Zhaoyong Hu, Dong Zhou, Yanlin Wang
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	British Journal of Pharmacology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Irisin‐mediated muscle‐renal crosstalk as a protective mechanism against contrast‐induced acute kidney injury via cGAS‐STING signalling inhibition
von: Long Peng, et al.
Veröffentlicht: (2025)

Nerandomilast, a PDE4B inhibitor, alleviates silica‐induced lung inflammation and fibrosis by inhibition of NLRP3 inflammasome and TGF‐β/Smad signalling
von: Yuanying Wang, et al.
Veröffentlicht: (2025)

Diminished nuclear‐localized β‐adrenoceptor signalling activates YAP to promote kidney fibrosis in diabetic nephropathy
von: Wenjing Xiang, et al.
Veröffentlicht: (2024)

TRPC6 suppresses liver fibrosis by inhibiting hepatic stellate cell activation via CaMK4‐CREB pathway
von: Shan Jiang, et al.
Veröffentlicht: (2025)

Monovalent glycoconjugates of sulforaphane prevent inflammation induced by lipopolysaccharide in human dendritic cells by inhibiting NF‐ĸB signalling pathway
von: Camila Leiva‐Castro, et al.
Veröffentlicht: (2025)

Targeting protein condensation in cGAS‐STING signaling pathway
von: Yajie Li, et al.
Veröffentlicht: (2024)

cGAS–STING, an important signaling pathway in diseases and their therapy
von: Qijie Li, et al.
Veröffentlicht: (2024)

Bruton's tyrosine kinase inhibition suppresses pathological retinal angiogenesis
von: Siyue Chen, et al.
Veröffentlicht: (2024)

Pharmacological inhibition of STING reduces neuroinflammation‐mediated damage post‐traumatic brain injury
von: Amelia L. Fryer, et al.
Veröffentlicht: (2024)

Daucosterol ameliorates acute inflammation and fibrosis following myocardial infarction via regulation of the ZBTB16 protein
von: Shihao Sheng, et al.
Veröffentlicht: (2025)

Bispecific nanobody® as a new pharmacological drug for the selective inhibition of Trypsin‐3
von: Melissa David, et al.
Veröffentlicht: (2025)

Investigation and Regulation of DNA Nanostructures on Activating cGAS‐STING Signaling
von: Kexuan Zou, et al.
Veröffentlicht: (2024)

Dimethyl fumarate alleviate hepatic ischemia–reperfusion injury through suppressing cGAS‐STING signaling
von: Yi Xiong, et al.
Veröffentlicht: (2025)

Beyond TGFβ inhibition: Chitosan oligosaccharide targets PGC‐1α‐mediated mitochondrial repair to combat pulmonary fibrosis
von: Huan He, et al.
Veröffentlicht: (2025)

Echinococcus granulosus antigen B regulates T‐cell function through inhibition of signal transducer and activator of transcription 3 in experimental immune thrombocytopenia
von: Yingbin Yue, et al.
Veröffentlicht: (2025)

Epigenetic silencing and pharmacological inhibition of EIF5A2 foster venetoclax sensitivity in acute myeloid leukaemia
von: Eva Crespo‐García, et al.
Veröffentlicht: (2026)

Neurokinin‐1 receptor activation protects against cardiac fibrosis, inflammation and diastolic dysfunction in type 2 diabetic mice
von: Alexander Widiapradja, et al.
Veröffentlicht: (2026)

Correction to “AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis”
Veröffentlicht: (2024)

Tryptophan 2,3‐dioxygenase deficiency attenuates dextran sodium sulphate –induced ulcerative colitis in mice by suppressing macrophage polarisation and reducing intestinal epithelial cell apoptosis
von: Weibo Dong, et al.
Veröffentlicht: (2026)

Inhibition of DOCK1 suppresses Notch signalling pathway and impairs leukaemogenesis
von: Ming‐En Lin, et al.
Veröffentlicht: (2025)

Kurarinone Alleviates cGAS ‐ STING ‐Triggered Inflammatory Diseases by Targeting STING
von: Lu Liu, et al.
Veröffentlicht: (2025)

Ligustilide alleviates hepatic fibrosis by targeting the mesenchymal homeobox 1 (MEOX1)– transcriptional enhanced associate domain factor 2 (TEAD2) signalling axis
von: Qinrong Luan, et al.
Veröffentlicht: (2026)

CKIP‐1 silencing suppresses OSCC via mitochondrial homeostasis‐associated TFAM/cGAS‐STING signalling axis
von: Ji‐Rong Xie, et al.
Veröffentlicht: (2024)

Tert‐butylhydroquinone promotes skin flap survival by inhibiting oxidative stress mediated by the Nrf2/HO‐1 signalling pathway
von: Kaitao Wang, et al.
Veröffentlicht: (2024)

Microglial forkhead box O3a deficiency attenuates LPS‐induced neuro‐inflammation and depressive‐like behaviour through regulating the expression of peroxisome proliferator‐activated receptor‐γ
von: Rikang Wang, et al.
Veröffentlicht: (2024)

GL‐V9 inhibits Caspase‐11 activation‐induced pyroptosis by suppressing ALOX12‐mediated lipid peroxidation to alleviate sepsis
von: Li Chen, et al.
Veröffentlicht: (2025)

P2X7 receptor antagonism suppresses epileptiform‐like activity in an inflammation‐primed human iPSC‐derived neuron model of drug‐resistant epilepsy
von: Jaideep Kesavan, et al.
Veröffentlicht: (2025)

PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells
von: Dennis Reininger, et al.
Veröffentlicht: (2024)

cGAS‐STING Pathway's Impact on Intestinal Barrier
von: Liqi Li, et al.
Veröffentlicht: (2025)

Different Expressions and Methylation Patterns of cGAS and STING in Cervical Cancer
von: Ruimin Wang, et al.
Veröffentlicht: (2026)

Oroxylin A attenuates psoriasiform skin inflammation by direct targeting p62 (sequestosome 1) via suppressing M1 macrophage polarization
von: Yuxiang Ma, et al.
Veröffentlicht: (2024)

Macrocyclic diterpenoids from Stellera chamaejasme roots alleviate imiquimod‐induced psoriasiform inflammation via STAT1/S100A9 signalling pathway
von: Yi‐Wen Nie, et al.
Veröffentlicht: (2025)

Incorrigible inflammation
von: Hany Ariffin
Veröffentlicht: (2024)

Compartmentalisation in cAMP signalling: A phase separation perspective
von: Milda Folkmanaite, et al.
Veröffentlicht: (2025)

Resolution pharmacology and the treatment of infectious diseases
von: Vivian Vasconcelos Costa, et al.
Veröffentlicht: (2024)

Osthole targets doublecortin like kinase 1 (DCLK1/DCAMKL1) in macrophages to inhibit NF‐κB‐mediated inflammation and alleviate atherosclerosis
von: Sirui Shen, et al.
Veröffentlicht: (2026)

Natural product pharmacology: the British Journal of Pharmacology perspective
von: Xin Wang, et al.
Veröffentlicht: (2024)

Clinical pharmacology considerations and drug–drug interactions with long‐acting cabotegravir and rilpivirine relevant to sub‐Saharan Africa
von: Adrian Steulet, et al.
Veröffentlicht: (2024)

Anti‐chitinase‐3‐like 1 antibody attenuated atopic dermatitis‐like skin inflammation through inhibition of STAT3‐dependent CXCL8 expression
von: Ji Eun Yu, et al.
Veröffentlicht: (2024)

Network‐based precision medicine and systems pharmacology
von: Arvind K. Pandey, et al.
Veröffentlicht: (2025)